3//SEC Filing
Avista Capital Managing Member IV, LLC 3
Accession 0001140361-18-045044
CIK 0001661181other
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 9:34 PM ET
Size
43.5 KB
Accession
0001140361-18-045044
Insider Transaction Report
Form 3
Holdings
- 9,022,741(indirect: See Notes)
Class A Common Stock
- (indirect: See Notes)
Warrants
From: 2019-01-09Exp: 2023-12-10→ Class A common stock (2,050,000 underlying)
Avista Capital Partners IV, L.P.
10% Owner
Holdings
- 9,022,741(indirect: See Notes)
Class A Common Stock
- (indirect: See Notes)
Warrants
From: 2019-01-09Exp: 2023-12-10→ Class A common stock (2,050,000 underlying)
Holdings
- 9,022,741(indirect: See Notes)
Class A Common Stock
- (indirect: See Notes)
Warrants
From: 2019-01-09Exp: 2023-12-10→ Class A common stock (2,050,000 underlying)
Avista Capital Partners IV GP, L.P.
10% Owner
Holdings
- 9,022,741(indirect: See Notes)
Class A Common Stock
- (indirect: See Notes)
Warrants
From: 2019-01-09Exp: 2023-12-10→ Class A common stock (2,050,000 underlying)
Footnotes (6)
- [F1]This statement is being filed by the following Reporting Persons: Avista Capital Partners IV, L.P. ("Fund IV"), Avista Capital Partners (Offshore) IV, L.P. ("Offshore Fund IV"), Avista Capital Partners IV GP, L.P. ("Fund IV GP"), which is the general partner of Fund IV and Offshore Fund IV; and Avista Capital Managing Member IV, LLC ("Fund IV GP Managing Member"), which is the general partner of Fund IV GP.
- [F2]Represents 4,523,497 shares of Class A common stock owned directly by Fund IV and 4,499,244 shares of Class A common stock owned directly by Offshore Fund IV, in each case, following the completion of a private placement by Avista Healthcare Public Acquisition Corp. (the "Issuer").
- [F3]Represents 2,055,510 warrants to purchase 1,027,755 shares of Class A common stock owned directly by Fund IV and 2,044,490 warrants to purchase 1,022,245 shares of Class A common stock owned directly by Offshore Fund IV, in each case, following the completion of a private placement by the Issuer.
- [F4]Each warrant entitles the holder to purchase from the Issuer the number of shares of Class A common stock at the price of $5.75 per half-share (or $11.50 per whole share), subject to adjustments.
- [F5]Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.
- [F6]Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.
Documents
Issuer
Organogenesis Holdings Inc.
CIK 0001661181
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001761175
Filing Metadata
- Form type
- 3
- Filed
- Dec 11, 7:00 PM ET
- Accepted
- Dec 12, 9:34 PM ET
- Size
- 43.5 KB